Skip to Content

2seventy bio Inc Ordinary Shares TSVT

Morningstar Rating
$5.96 +0.46 (8.36%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TSVT is trading at a 46% discount.
Price
$5.51
Fair Value
$18.78
Uncertainty
Extreme
1-Star Price
$43.30
5-Star Price
$4.23
Economic Moat
Tqdk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TSVT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$5.50
Day Range
$5.505.98
52-Week Range
$1.5413.97
Bid/Ask
$5.70 / $6.00
Market Cap
$301.72 Mil
Volume/Avg
947,180 / 1.5 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.88
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
425

Comparables

Valuation

Metric
TSVT
SLRN
VOR
Price/Earnings (Normalized)
Price/Book Value
0.981.110.76
Price/Sales
1.88
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
TSVT
SLRN
VOR
Quick Ratio
3.9711.8210.40
Current Ratio
4.0811.8810.69
Interest Coverage
Quick Ratio
TSVT
SLRN
VOR

Profitability

Metric
TSVT
SLRN
VOR
Return on Assets (Normalized)
−18.29%−82.97%−39.83%
Return on Equity (Normalized)
−36.98%−147.10%−49.16%
Return on Invested Capital (Normalized)
−22.45%−153.91%−44.31%
Return on Assets
TSVT
SLRN
VOR
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRZlx$541.7 Bil
VRTX
Vertex Pharmaceuticals IncBjfsbl$111.3 Bil
REGN
Regeneron Pharmaceuticals IncVgqkx$109.1 Bil
MRNA
Moderna IncNryq$36.8 Bil
ARGX
argenx SE ADRDxpvf$24.3 Bil
BNTX
BioNTech SE ADRDfh$22.0 Bil
ALNY
Alnylam Pharmaceuticals IncXgzrp$20.0 Bil
BMRN
Biomarin Pharmaceutical IncFjghkc$17.1 Bil
RPRX
Royalty Pharma PLC Class AVvtxqs$14.0 Bil
INCY
Incyte CorpXyvzmnq$13.7 Bil

Sponsor Center